N-Acetyl Epithalon Amidate is a modified synthetic tetrapeptide bioregulator actively investigated for its roles in telomerase activation, telomere maintenance, and circadian biology. Developed to offer enhanced enzymatic stability over its parent compound, this peptide serves as a primary tool in preclinical cellular senescence and longevity research.
N-Acetyl Epithalon Amidate is a modified synthetic tetrapeptide bioregulator actively investigated for its roles in telomerase activation, telomere maintenance, and circadian biology. Developed to offer enhanced enzymatic stability over its parent compound, this peptide serves as a primary tool in preclinical cellular senescence and longevity research.
N-acetyl epithalon amidate is a synthetic tetrapeptide analog derived from Epithalon (L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-glycine), featuring N-terminal acetylation and C-terminal amidation. Designed for enhanced enzymatic stability in laboratory assays, this bioregulator is primarily investigated in preclinical models for its ability to induce telomerase activity, support telomere maintenance, and modulate circadian pineal function.
The molecular modification of peptide termines—specifically capping the N-terminus with an acetyl group and the C-terminus with an primary amide group—is a standard bioorganic strategy aimed at conferring resistance against exopeptidases. Aminopeptidases and carboxypeptidases present in culture media or tissue homogenates rapidly cleave unmodified short-chain peptides. By blocking these terminal cleavage sites, scientists can observe prolonged biological activity and stabilized signaling in vitro and in vivo.
As part of the broader peptide bioregulator family, N-acetyl epithalon amidate is utilized exclusively in cell culture, biochemical assays, and non-human model systems to elucidate the mechanics of cellular aging, chromatin structure, and gene expression regulation. Researchers comparing various modified analogs frequently consult the complete comprehensive research peptides catalog to identify suitable bioregulatory controls.
The chemical structure of parent Epithalon consists of four amino acids: Ala-Glu-Asp-Gly. While effective in early Russian peptide bioregulation models, the unmodified tetrapeptide possesses exposed charged ends—a free amino group at the N-terminus and a free carboxyl group at the C-terminus. These terminal functional groups render the molecule vulnerable to rapid degradation by circulating or intracellular peptidases.
N-terminal acetylation alters the overall charge state of the N-terminal alanine residue, converting an amine into a neutral amide linkage. Concurrently, C-terminal amidation converts the terminal carboxyl group of glycine into an uncharged carboxamide. These modifications combined alter the hydrodynamic radius, lipophilicity, and hydrogen-bonding potential of the peptide without compromising its core functional domain.
In physical chemistry assays, acetylated and amidated short peptides frequently demonstrate altered retention times during reversed-phase high-performance liquid chromatography (RP-HPLC) compared to their native counterparts. Understanding these physicochemical changes is essential for analytical chemists verifying lot purity and evaluating peptide solubility across various buffer formulations.
Peptide bioregulators function primarily through specific interaction with the promoter regions of DNA and histone proteins, inducing targeted gene expression. Preclinical studies suggest that short peptide sequences, including Epithalon derivatives, are capable of penetrating the nuclear membrane and binding directly to specific double-stranded or single-stranded DNA sequences in the major groove.
Upon binding, these short peptide chains interact with histone tails, promoting chromatin relaxation (euchromatin formation). This structural shift renders previously silenced or down-regulated genomic regions accessible to RNA polymerase II and transcription factors. In the case of N-acetyl epithalon amidate, researchers focus on how modified terminal groups affect the kinetic binding affinity to chromatin compared to the parent molecule.
In vitro data indicate that this bioregulatory signal cascade leads to the upregulation of specific target proteins without causing non-specific genomic alteration. Detailed mechanisms of peptide-chromatin interactions are documented extensively within the PX1 Research knowledge base, which catalogues mechanistic literature across diverse bioregulatory families.
Telomeres are repetitive nucleoprotein complexes (TTAGGG repeats) situated at the ends of eukaryotic chromosomes that protect genomic DNA from degradation and end-to-end fusion. With each cycle of somatic cell division, telomeric DNA progressively shortens, eventually triggering replicative senescence or apoptosis when a critical threshold (the Hayflick limit) is reached.
Telomerase is a ribonucleoprotein reverse transcriptase enzyme (composed of TERT and TERC subunits) that synthesizes telomeric repeats de novo. In normal somatic cells, TERT gene expression is tightly repressed. Animal models and human somatic cell line studies demonstrate that Epithalon and its modified analogs induce the expression of the catalytic subunit of telomerase (TERT), resulting in telomerase activation.
By re-activating telomerase, preclinical assays have documented elongation of telomeric repeats and an extension of the functional replicative lifespan in cultured human fibroblasts and fetal somatic cells. N-acetyl epithalon amidate is specifically selected for long-term cell culture studies where sustained compound integrity is required over multi-week passage protocols.
Beyond chromosomal maintenance, pineal-derived short peptides play an established role in regulating neuroendocrine pathways and neuroendocrine homeostasis. The pineal gland synthesizes melatonin, a critical hormone governing circadian rhythms, antioxidant defense, and seasonal biological processes. Aging is characteristically accompanied by pineal involution and a marked decline in nocturnal melatonin secretion.
Preclinical research in aging rodent models indicates that administration of pineal tetrapeptides restores nocturnal melatonin synthesis, normalizes gonadotropin secretion, and re-establishes physiological circadian rhythms. In vitro pinealocyte cultures exposed to N-acetyl epithalon amidate demonstrate enhanced expression of arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin biosynthesis.
By modulating pineal activity, researchers investigate the downstream effects on systemic oxidative stress, immune surveillance, and glucose tolerance. The interplay between pineal bioregulation and systemic longevity pathways remains a focal area of current preclinical biogerontology.
To properly evaluate N-acetyl epithalon amidate within a research design, it is useful to compare its functional profile with other widely studied short-chain bioregulatory peptides. While all bioregulators share low molecular weights and gene-modulating capabilities, their tissue specificity and primary molecular targets differ substantially.
For instance, direct comparison with the parent compound is detailed in our Epithalon research overview, highlighting differences in half-life, enzymatic susceptibility, and binding kinetics. Similarly, researchers investigating neuroprotection and cognitive aging models often utilize Pinealon research profile assays, as Pinealon selectively targets brain-derived neurotrophic factors and neuronal gene networks. In immunogerontology models, Thymalin bioregulatory mechanisms are evaluated for restoring T-cell differentiation and thymic epithelial function.
The following matrix summarizes the distinct experimental parameters of these primary bioregulatory compounds in laboratory settings:
• N-Acetyl Epithalon Amidate: Target tissues include pineal gland, chromatin structure, and somatic cell telomeres. Primary parameters investigated are TERT activation, telomere elongation, enzymatic stability, and circadian melatonin rhythmicity. • Standard Epithalon (Unmodified): Target tissues include pineal gland and somatic telomeres. Primary parameters investigated are basic telomerase induction and pineal hormone production, though subject to rapid enzymatic hydrolysis in bio-assays. • Pinealon (Glu-Asp-Arg): Target tissues include central nervous system and hippocampal neurons. Primary parameters investigated are neuroprotection, reactive oxygen species (ROS) reduction, and cognitive performance markers in aged rodent models. • Thymalin: Target tissues include thymus gland and peripheral immune system. Primary parameters investigated are T-lymphocyte maturation, cytokine modulation, and immune senescence reversal.
Selecting the correct bioregological control depends heavily on whether the assay requires prolonged incubation in enzymatic media (favoring N-acetyl epithalon amidate) or immediate tissue-specific cell surface receptor signaling.
N-acetyl epithalon amidate is typically supplied as a lyophilized (freeze-dried) white powder in sealed glass vials under vacuum or inert gas flushing. To maintain molecular integrity, research facilities must adhere to standard peptide handling procedures during reconstitution and storage.
Reconstitution should be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or phosphate-buffered saline (PBS, pH 7.4), depending on the specific downstream assay requirement. For cell culture experiments requiring strictly sterile, preservative-free conditions, sterile endotoxin-free water or PBS is recommended. Gentle swirl agitation should be used; vigorous vortexing or mechanical shaking must be avoided to prevent surface-denaturation or aggregation.
Lyophilized vials should be stored at -20°C or -80°C for long-term stability. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide bonds. Reconstituted aliquots are typically stable at 4°C for up to 7–14 days, or at -20°C for up to 3–6 months. Comprehensive storage specifications are available in our peptide stability and storage guide.
Because small structural impurities or remnant reagents from solid-phase peptide synthesis (SPPS) can significantly distort cell assay outcomes, strict analytical verification is non-negotiable for research-grade materials.
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is used to establish chemical purity. A high-purity batch of N-acetyl epithalon amidate should display a single sharp chromatogram peak, achieving ≥98.0% purity area under the curve (AUC). Liquid Chromatography-Mass Spectrometry (LC-MS) or Electrospray Ionization Mass Spectrometry (ESI-MS) is concurrently run to confirm the exact monoisotopic molecular mass and verify the presence of both the N-acetyl and C-amidate chemical modifications.
Furthermore, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assay is critical for cell culture applications. High endotoxin levels trigger non-specific inflammatory signaling pathways via Toll-like receptor 4 (TLR4), confounding cellular response data. Research-grade peptides provided by PX1 Research are held to rigorous endotoxin thresholds (<0.1 EU/mg).
When procuring peptides for academic, industrial, or institutional research, verifying supplier credentials and batch documentation is essential. Every batch of N-acetyl epithalon amidate must be accompanied by an independent, third-party Certificate of Analysis (COA) containing lot-specific analytical data.
A valid COA must report: (1) Lot number matching the physical vial, (2) RP-HPLC chromatograms showing relative purity percentage, (3) Mass spectrum confirming exact mass, (4) Quantitative endotoxin level, and (5) Net peptide content / net mass verification. Generic COAs or non-independent manufacturer internal sheets do not provide sufficient rigor for peer-reviewed science.
PX1 Research manufactures peptides in USA-based, ISO 17025-accredited or GMP-compliant facilities. Every lot is independently audited by third-party analytical laboratories. Principal investigators requiring bulk quantities or dedicated lot reservation can establish custom parameters via our bulk research accounts portal.
What is the primary difference between Epithalon and N-Acetyl Epithalon Amidate?
N-Acetyl Epithalon Amidate features chemical modifications at both ends of the tetrapeptide chain (N-terminal acetylation and C-terminal amidation). These terminal caps protect the compound from rapid exopeptidase cleavage in biological media, increasing half-life and stability in experimental assays compared to native Epithalon.
What is the molecular mechanism of N-Acetyl Epithalon Amidate?
Preclinical models show that N-acetyl epithalon amidate interacts directly with DNA promoter regions and histone complexes, inducing euchromatin formation. This leads to the transcriptional upregulation of TERT (telomerase reverse transcriptase) and enzymes involved in pineal melatonin synthesis.
Is N-Acetyl Epithalon Amidate suitable for human consumption or clinical use?
No. N-Acetyl Epithalon Amidate is strictly a research chemical designated for laboratory, in vitro, and preclinical animal research only. It is not approved for clinical, human, or veterinary use.
How should N-Acetyl Epithalon Amidate be reconstituted for laboratory assays?
The lyophilized powder should be reconstituted using sterile Bacteriostatic Water, sterile saline, or PBS (pH 7.4) depending on the assay protocol. Gently swirl the vial until dissolved. Avoid high-shear mechanical mixing or vortexing.
What purity level is required for research-grade N-Acetyl Epithalon Amidate?
Standard research protocols require a minimum chemical purity of ≥98.0% as determined by RP-HPLC. Additionally, low endotoxin levels (<0.1 EU/mg) are necessary to avoid non-specific cellular inflammatory responses.
How should reconstituted N-Acetyl Epithalon Amidate be stored?
Once reconstituted into solution, the liquid should be divided into single-use aliquots to avoid freeze-thaw cycles. Store aliquots at 4°C for short-term use (up to 7–14 days) or -20°C to -80°C for long-term storage.
Does PX1 Research provide a Certificate of Analysis (COA) for each lot?
Yes. Every lot of N-Acetyl Epithalon Amidate supplied by PX1 Research includes a lot-specific, third-party Certificate of Analysis detailing RP-HPLC purity, mass spectrometry verification, and quantitative LAL endotoxin testing.
Where are PX1 Research peptides manufactured and shipped from?
PX1 Research peptides are manufactured in US-based facilities operating under strict quality standards. Orders are fulfilled and shipped directly from our warehouse facilities located in California and Arizona, with same-day dispatch available Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.